The EHA / Moving Forward team has asked Bernhard Landwehrmeyer, the Founder of the European Huntington’s Disease Network (EHDN) and the Principal Investigator of the Enroll-HD study, to share his view about the impact of the HD gene discovery on the HD clinical and research landscapes.
The video is in 🇬🇧 English, with 🇪🇸 Spanish subtitles.